Analyst Recommendations
5.10 0.11(2.10%)09/13/2024
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc (VNDA)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Overweight | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades